Nabil F. Saba
Emory University(US)Piedmont Cancer Institute(US)Vanderbilt University Medical Center(US)
Publications by Year
Research Areas
Head and Neck Cancer Studies, Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Cancer Diagnosis and Treatment, Head and Neck Surgical Oncology
Most-Cited Works
- → Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck(2016)4,969 cited
- → Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression(2018)786 cited
- → Head and neck cancer(2021)774 cited
- → An update on larynx cancer(2016)691 cited
- → Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study(2017)643 cited
- → Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial(2017)421 cited